AstraZeneca kept by Bear Stearns at outperform

AstraZeneca plc was maintained by Bear Stearns analyst Alexandra Hauber at an outperform rating with a price target on the stock of £27.30 per share following published results of the long-awaited study that compared AstraZeneca's Seroquel to Eli Lilly & Co.'s Zyprexa for schizophrenia. In London, AstraZeneca shares Tuesday were down 31p, or 1.18%, at 2,606p on volume of 8,670,111 shares versus the three-month running average of 6,054,710 shares. In the United States, AstraZeneca shares Tuesday were down $1.02, or 2.13%, at $46.78 on volume of 1,096,000 shares versus the three-month running average of 873,602 shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.